XML 81 R33.htm IDEA: XBRL DOCUMENT v3.22.4
Equity Incentive Plans (Tables)
12 Months Ended
Dec. 31, 2022
Nonvested Restricted Stock Shares Activity RSU activity for the year ended December 31, 2022 was as follows:

 

 

 

Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Unvested at December 31, 2021

 

 

 

 

$

 

Granted

 

 

581,047

 

 

 

26.25

 

Vested and released

 

 

(79,229

)

 

 

24.79

 

Cancelled

 

 

(45,052

)

 

 

24.32

 

Unvested at December 31, 2022

 

 

456,766

 

 

$

26.70

 

Summary of Activity under Employee Stock Purchase Plan Activity under our 2020 ESPP was as follows:

 

 

Shares

 

Balance - December 31, 2019

 

 

 

Shares authorized

 

 

650,000

 

Shares purchased

 

 

(27,465

)

Balance - December 31, 2020

 

 

622,535

 

Additional shares authorized

 

 

510,715

 

Shares purchased

 

 

(62,546

)

Balance - December 31, 2021

 

 

1,070,704

 

Additional shares authorized

 

 

530,319

 

Shares purchased

 

 

(61,709

)

Balance - December 31, 2022

 

 

1,539,314

 

 

Summary of Estimated Fair Value of Employee Stock Options

We estimated the fair value of employee stock options using the Black-Scholes option-pricing model for the years ended December 31, 2022, 2021 and 2020 using the following weighted-average assumptions:

 

 

 

Year Ended December 31,

 

 

2022

 

2021

 

2020

Fair Value Assumptions

 

 

 

 

 

 

Expected volatility

 

78.1% - 85.1%

 

81.0% - 84.1%

 

81.2% - 94.1%

Expected dividend yield

 

0%

 

0%

 

0%

Expected term (in years)

 

5.3 - 5.5

 

5.3 - 5.5

 

5.6 - 6.1

Risk-free interest rate

 

1.6% - 4.4%

 

0.5% - 1.3%

 

0.3% - 1.4%

2020 Plan and 2014 Plan  
Summary of Activity Under Stock Option Plans

Stock option activity under our 2020 Plan and 2014 Plan, which excludes options to purchase 36,710 shares granted outside of the 2020 Plan and 2014 Plan, was as follows:

 

 

 

 

 

 

Options Outstanding

 

Stock Option and Restricted Stock Units Activity

 

Options
and RSUs
Available
for
Grant

 

 

Number
of
Options

 

 

Weighted-
Average
Exercise
Price Per
Share

 

 

Weighted-
Average
Remaining
Contractual
Term
(Years)

 

 

Aggregate
Intrinsic
Value

 

Balances — December 31, 2020

 

 

4,651,149

 

 

 

5,121,549

 

 

$

4.99

 

 

 

 

 

 

 

Additional shares authorized

 

 

2,553,579

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

(1,616,021

)

 

 

1,616,021

 

 

$

21.83

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

(926,514

)

 

$

3.25

 

 

 

 

 

 

 

Options forfeited

 

 

516,049

 

 

 

(516,049

)

 

$

16.70

 

 

 

 

 

 

 

Balances — December 31, 2021

 

 

6,104,756

 

 

 

5,295,007

 

 

$

9.30

 

 

 

 

 

 

 

Additional shares authorized

 

 

2,651,598

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

(3,850,981

)

 

 

3,850,981

 

 

$

27.67

 

 

 

 

 

 

 

Options exercised

 

 

385

 

(1)

 

(1,153,285

)

 

$

4.25

 

 

 

 

 

 

 

Options forfeited

 

 

277,209

 

 

 

(277,209

)

 

$

23.54

 

 

 

 

 

 

 

Restricted Stock Units granted

 

 

(581,047

)

 

 

 

 

 

 

 

 

 

 

 

 

Restricted Stock Units withheld

 

 

32,626

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted Stock Units forfeited

 

 

45,052

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances — December 31, 2022

 

 

4,679,598

 

 

 

7,715,494

 

 

$

18.70

 

 

 

8.20

 

 

$

225,667

 

Vested and expected to vest — December 31, 2022

 

 

 

 

 

7,715,494

 

 

$

18.70

 

 

 

8.20

 

 

$

225,667

 

Exercisable at December 31, 2022

 

 

 

 

 

2,921,091

 

 

$

9.41

 

 

 

6.81

 

 

$

112,585

 

______________________________________

(1)
Net exercise - shares returned to the Plan.
2020 Employee Stock Purchase Plan  
Summary of Estimated Fair Value of Shares Under Employee Stock Purchase Plan

We estimated the fair value of shares under the 2020 ESPP using the Black-Scholes option-pricing model for the years ended December 31, 2022, 2021 and 2020 using the following weighted-average assumptions:

 

 

 

Year Ended December 31,

 

 

2022

 

2021

 

2020

Fair Value Assumptions

 

 

 

 

 

 

Expected volatility

 

78.8% - 99.7%

 

79.6% - 126.3%

 

105.8% - 158.2%

Expected dividend yield

 

0%

 

0%

 

0%

Expected term (in years)

 

0.5 - 2.0

 

0.5 - 2.0

 

0.4 - 2.0

Risk-free interest rate

 

0.1% - 4.7%

 

0.0% - 0.5%

 

0.1% - 0.2%

2014 Plan, 2020 Plan and 2020 ESPP  
Summary of Stock-based Compensation Expense

We recorded total stock-based compensation expense for the years ended December 31, 2022, 2021 and 2020 related to the 2014 Plan, the 2020 Plan and the 2020 ESPP in the statements of operations and allocated the amounts as follows:

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

 

 

(In thousands)

 

Research and development

 

$

9,899

 

 

$

3,954

 

 

$

1,861

 

General and administrative

 

 

13,751

 

 

 

6,775

 

 

 

3,573

 

Total

 

$

23,650

 

 

$

10,729

 

 

$

5,434